1515 Holcombe Blvd, Houston, TX, 77030 · (713) 792-2121
Beds
764
FY 2025
Star rating
Not rated
Overall rating
Net patient revenue
$5.42B
FY 2025
Net income
$1.57B
Patient care margin -9.6%
Discharges
30,471
Occupancy 85.7%
Clinicians
2,814
Medicare clinicians who work here
From the hospital's yearly cost reports (fiscal years as the hospital reports them)
Locations are shown at the center of the ZIP code.
US dollars as reported. Patient care margin = net patient revenue minus operating expenses, before other income such as grants, donations and investments.
| Fiscal year | Net patient revenue | Operating expenses | Patient care margin | Net income | Discharges | Uncompensated care | Medicare days | Medicaid days |
|---|---|---|---|---|---|---|---|---|
| 2025 | $5.42B | $5.94B | -9.6% | $1.57B | 30,471 | - | 31.6% | 0.5% |
Medicare clinicians who list this hospital, by specialty
Hospital outpatient services by payment group (APC), 2024
| Service group | Services | Patients | Medicare pays per service | All hospitals |
|---|---|---|---|---|
| APC 5072 Level 2 Excision/ Biopsy/ Incision and Drainage | 3,472 | 3,019 | $1,183.81 | $1,219.56 |
| APC 5073 Level 3 Excision/ Biopsy/ Incision and Drainage | 3,313 | 2,275 | $2,086.30 | $2,141.49 |
| APC 5372 Level 2 Urology and Related Services |
Official US government data: hospital records, ownership records, yearly cost reports and quality measures, linked by the hospital's CCN and NPI. Financials are for fiscal years as reported by the hospital.
| 2024 | $6.06B | $5.47B | 9.8% | $1.45B | 29,931 | - | 32.0% | 0.5% |
| 2023 | $4.90B | $4.94B | -0.8% | $931.0M | 29,176 | - | 32.3% | 0.5% |
| 2022 | $4.40B | $4.50B | -2.3% | $36.0M | 28,736 | - | 34.9% | 0.7% |
| 2021 | $3.98B | $4.06B | -2.0% | $1.78B | 26,908 | - | 32.8% | 0.9% |
| 2020 | $3.67B | $3.92B | -6.7% | $697.7M | 25,832 | - | 34.2% | 1.1% |
| 3,043 |
| 1,012 |
| $493.37 |
| $502.15 |
| APC 8011 Comprehensive Observation Services | 1,050 | 913 | $1,992.76 | $2,090.36 |
| APC 5302 Level 2 Upper GI Procedures | 969 | 711 | $1,398.34 | $1,444.50 |
| APC 5373 Level 3 Urology and Related Services | 858 | 590 | $1,488.72 | $1,516.28 |
| APC 5183 Level 3 Vascular Procedures | 842 | 817 | $2,329.29 | $2,405.01 |
| APC 5182 Level 2 Vascular Procedures | 586 | 563 | $1,168.45 | $1,204.32 |
| APC 5154 Level 4 Airway Endoscopy | 555 | 536 | $2,720.78 | $2,832.62 |
| APC 5374 Level 4 Urology and Related Services | 521 | 451 | $2,559.00 | $2,629.24 |
| APC 5092 Level 2 Breast/Lymphatic Surgery and Related Procedures | 469 | 463 | $4,786.88 | $4,981.95 |
| APC 5375 Level 5 Urology and Related Services | 422 | 396 | $3,799.65 | $3,917.51 |
Reported payments to this teaching hospital
| Company | Payments | Amount |
|---|---|---|
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 66 | $38.0M |
| AstraZeneca Pharmaceuticals LP AZN | 63 | $31.3M |
| Merck Sharp & Dohme LLC MRK | 109 | $26.7M |
| Amgen Inc. AMGN | 34 | $24.1M |
| Pfizer Inc. PFE | 474 | $22.4M |
| E.R. Squibb & Sons, L.L.C. BMY | 79 | $18.2M |
| Abbvie Inc. ABBV | 866 | $16.5M |
| Servier Pharmaceuticals LLC | 26 | $9.8M |
| Regeneron Pharmaceuticals, Inc. REGN | 791 | $9.2M |
| Celgene Corporation BMY | 31 | $6.4M |
Official US government data on Original Medicare hospital stays and outpatient services; groups with fewer than 11 cases are not published. Payments are those drug and device companies must report.
University of Texas M D Anderson Cancer Center is a government-owned short-term acute care hospital in Houston, TX with 764 beds, part of The University of Texas System.
University of Texas M D Anderson Cancer Center in Houston, TX has 764 beds (fiscal year 2025 cost report); 666 beds are certified for Medicare. It discharged 30,471 inpatients that year, with 85.7% of its beds in use on average.
In fiscal year 2025 (ending 2025-08-31), University of Texas M D Anderson Cancer Center reported net patient revenue of $5.42B and operating expenses of $5.94B, a margin on patient care of -9.6%. After other income and expenses its net income was $1.57B (20.9% of revenue), so it made a profit that year.
University of Texas M D Anderson Cancer Center is part of The University of Texas System, a health system with 5 hospitals based in Austin, TX. It is a government-owned hospital.
University of Texas M D Anderson Cancer Center has no overall star rating, usually because it reports too few quality measures (for example small, specialty or federal hospitals).
Yes, University of Texas M D Anderson Cancer Center provides emergency services.
2,814 Medicare clinicians list University of Texas M D Anderson Cancer Center as a hospital they work at, most often in Nurse Practitioner, Physician Assistant, Diagnostic Radiology.
In 2025, companies reported $291.9M in payments to University of Texas M D Anderson Cancer Center as a teaching hospital ($5.7M general and $286.2M for research) from 161 companies.